Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (11-20 of 6,076) with videos related to

Pageof 608
Sort By:
The Prostate|March 2, 2011
Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κBDavid A Cavazos, Ramona S Price, Shruti S Apte, et al.
The Prostate|March 2, 2011
Gene expression pathways of high grade localized prostate cancerAshley E Ross, Luigi Marchionni, Milena Vuica-Ross, et al.
The Prostate|June 29, 2010
Expression of cancer/testis antigens in prostate cancer is associated with disease progressionTakahito Suyama, Takumi Shiraishi, Yu Zeng, et al.
The Prostate|August 19, 2010
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cellsAkira Yokomizo, Masaki Shiota, Eiji Kashiwagi, et al.
The Prostate|August 19, 2010
Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health StudyYunfei Wang, Anna M Ray, Emilie K Johnson, et al.
The Prostate|August 19, 2010
Long-term corticosterone treatment induced lobe-specific pathology in mouse prostateUlla Simanainen, Anita Lampinen, Holger Henneicke, et al.
The Prostate|July 13, 2010
Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathwaysYu-Wei Sun, Wei-Jan Huang, Che-Jen Hsiao, et al.
The Prostate|July 13, 2010
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptorsClaudio Festuccia, Donatella Dondi, Margherita Piccolella, et al.
The Prostate|July 13, 2010
Predictive models before and after radical prostatectomyUmberto Capitanio, Alberto Briganti, Andrea Gallina, et al.
The Prostate|September 16, 2010
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapyHai-Liang Zhang, Li-Feng Yang, Yao Zhu, et al.
Pageof 608

Showing results (11-20 of 6,076) with videos related to

Sort By:
Pageof 608
The Prostate|March 2, 2011
Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κBDavid A Cavazos, Ramona S Price, Shruti S Apte, et al.
The Prostate|March 2, 2011
Gene expression pathways of high grade localized prostate cancerAshley E Ross, Luigi Marchionni, Milena Vuica-Ross, et al.
The Prostate|June 29, 2010
Expression of cancer/testis antigens in prostate cancer is associated with disease progressionTakahito Suyama, Takumi Shiraishi, Yu Zeng, et al.
The Prostate|August 19, 2010
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cellsAkira Yokomizo, Masaki Shiota, Eiji Kashiwagi, et al.
The Prostate|August 19, 2010
Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health StudyYunfei Wang, Anna M Ray, Emilie K Johnson, et al.
The Prostate|August 19, 2010
Long-term corticosterone treatment induced lobe-specific pathology in mouse prostateUlla Simanainen, Anita Lampinen, Holger Henneicke, et al.
The Prostate|July 13, 2010
Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathwaysYu-Wei Sun, Wei-Jan Huang, Che-Jen Hsiao, et al.
The Prostate|July 13, 2010
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptorsClaudio Festuccia, Donatella Dondi, Margherita Piccolella, et al.
The Prostate|July 13, 2010
Predictive models before and after radical prostatectomyUmberto Capitanio, Alberto Briganti, Andrea Gallina, et al.
The Prostate|September 16, 2010
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapyHai-Liang Zhang, Li-Feng Yang, Yao Zhu, et al.
Pageof 608